top of page

All About Us

Daikso primarily provides mobile edge AI solutions that are always available in the field of medical screening.

​

We aim to leverage AI to make professional medical screenings more precise and efficient, eliminating the limitations of time and space so they can be performed anytime and anywhere. Ultimately, we want to achieve a level of accessibility where professional medical screenings can be as common as rapid tests and mass screenings, making them possible not only for specialists or in large hospitals with complex machinery.

​

The founder and co-founder have each dedicated over 30 years to the fields of medical imaging and AI, respectively. Leading top domestic talent in computer science and medical device regulations, and collaborating closely with experienced clinical medical consultants, we are committed to addressing unmet needs by providing innovative and practical smart medical AI solutions.

 Daikso's journey and growth.

2021

  • Ranked No.1 in Adaptive Computing Challenge 2021, AMD-Xilinx.

  • 8th place(1200+ teams) in validation phase - BraTS 2021, MICCAI.

0011.png

2022

  • Ranked No.1 in MICCAI DFUC 2022.

  • Daikso team raised NTD 12.7M/USD 0.4M in Angel round

  • Daikso Corporation was established in Taiwan.

  • Completed development of the prototype for a lightweight AI framework  on mobile/edge device.

0011.png

2023

  • Got medical device manufacturing license (Software), Taiwan
    (醫療器材製造商許可執照)

  • Approved by AI Program II, Ministry of Digital Affairs (數位發展部), R.O.C. with a total budget of NTD 12 million for the 2 years.

  • Completed the prototype of our Daikso Mobile Edge AI Solution
    (Ultrasound screening application).

  • Collaboration with ultrasound device companies. (MOUs signed.)

0011.png

2024

  • Got 1st Quality Management System (QMS) certificate. (品質管理系統)

  • Got 1st TFDA (戴克智慧醫學影像標註系統)

  • 1 TFDA are under review (expected to be obtained by the end of November, 2024)

0011.png
0014.png

Founder & Chairperson

Dr. Tzu-Chen Yen
 

0013.png

Dr. Youn-Long Lin

Co-founder & Director of Board

  • Director, Center for Advanced Molecular Imaging and Translation Attending Physician, Department of Nuclear Medicine, Chang Gung Memorial Hospital (長庚紀念醫院)

  • Chairperson of the board, Novascope Diagnostics Inc. (長典生物科技)

  • Chair Professor of CS, NTHU

  • Dean of Research & Development, NTHU

  • Co-founder, Global UniChip Corp. (創意電子)

  • CEO & Chairman of board, NEUCHIPS Corp. (創鑫智慧)

  • Ranks among the top 1% of scientists worldwide in the field of biomedical sciences (as of December 21, 2022).

  • The contribution to positron emission tomography (PET) has become a significant reference for Medicare reimbursement by the Centers for Medicare & Medicaid Services (CMS) in the United States.

  • More than 35 years of experience in AI architecture and IC design in both academia and industry.

  • Co-founder of Taiwan’s National Chip Implementation Center

  • Program director of the AI research Initiative sponsored by Taiwan’s Ministry of Science and Technology

Core Team

0015.png

Miles Wu

CEO

  • Master of CS, NTHU

  • HarDNet-MSEG co-Author

  • 8th place (1200+ teams), BraTS 2021 Challenge

0016.png

Edward Chang

COO

  • Master of EE, NYCU

  • Machine Learning Researcher, Princeton University.

  • Director of AI & SW, VesCir Ltd.

  • Senior Data Scientist, FiduciaEdge

0017.png

Wade Du

CTO

  • Bachelor of CS, NCCU

  • Product Lead, OSENSE Technology

  • Senior Backend Engineer, inqtech Co. Ltd.

0018.png

James Huang

VP & Leader of Data Analysis

  • Master of CS, NTHU

  • HarDNet-MSEG Author

  • ICCV 2019 - HarDNet co-author

  • Senior System Engineer, FiduciaEdge

Hsuan證件照.PNG

Hsuan Lu

Regulatory Affairs Specialist

  • Master of Health Industry Technology, CGUST

  • QMS Inpector, ITRI/CMS

  • Inspector, TFDA

bottom of page